MicroRNAs 185, 96, and 223 repress selective high-density lipoprotein cholesterol uptake through posttranscriptional inhibition L Wang, XJ Jia, HJ Jiang, Y Du, F Yang, SY Si, B Hong Molecular and cellular biology 33 (10), 1956-1964, 2013 | 186 | 2013 |
Butyrate protects against high‐fat diet‐induced atherosclerosis via up‐regulating ABCA1 expression in apolipoprotein E‐deficiency mice Y Du, X Li, C Su, M Xi, X Zhang, Z Jiang, L Wang, B Hong British Journal of Pharmacology 177 (8), 1754-1772, 2020 | 106 | 2020 |
Salvianolic acid B inhibits macrophage uptake of modified low density lipoprotein (mLDL) in a scavenger receptor CD36-dependent manner Y Bao, L Wang, Y Xu, Y Yang, L Wang, S Si, S Cho, B Hong Atherosclerosis 223 (1), 152-159, 2012 | 88 | 2012 |
Berberine attenuates choline-induced atherosclerosis by inhibiting trimethylamine and trimethylamine-N-oxide production via manipulating the gut microbiome X Li, C Su, Z Jiang, Y Yang, Y Zhang, M Yang, X Zhang, Y Du, J Zhang, ... npj Biofilms and Microbiomes 7 (1), 36, 2021 | 86 | 2021 |
MicroRNA-185 modulates low density lipoprotein receptor expression as a key posttranscriptional regulator H Jiang, J Zhang, Y Du, X Jia, F Yang, S Si, L Wang, B Hong Atherosclerosis 243 (2), 523-532, 2015 | 76 | 2015 |
Discovery of antagonists for human scavenger receptor CD36 via an ELISA-like high-throughput screening assay L Wang, Y Bao, Y Yang, Y Wu, X Chen, S Si, B Hong Journal of biomolecular screening 15 (3), 239-250, 2010 | 64 | 2010 |
Rutaecarpine suppresses atherosclerosis in ApoE−/− mice through upregulating ABCA1 and SR-BI within RCT Y Xu, Q Liu, Y Xu, C Liu, X Wang, X He, N Zhu, J Liu, Y Wu, Y Li, N Li, ... Journal of lipid research 55 (8), 1634-1647, 2014 | 63 | 2014 |
Identification of trichostatin A as a novel transcriptional up-regulator of scavenger receptor BI both in HepG2 and RAW 264.7 cells Y Bao, Y Yang, L Wang, L Gao, W Jiang, L Wang, S Si, B Hong Atherosclerosis 204 (1), 127-135, 2009 | 33 | 2009 |
Identification of two antagonists of the scavenger receptor CD36 using a high-throughput screening model Y Xu, J Wang, Y Bao, W Jiang, L Zuo, D Song, B Hong, S Si Analytical biochemistry 400 (2), 207-212, 2010 | 24 | 2010 |
Characterization of the isoflavone pratensein as a novel transcriptional up-regulator of scavenger receptor class B type I in HepG2 cells Y Yang, W Jiang, L Wang, ZB Zhang, SY Si, B Hong Biological and Pharmaceutical Bulletin 32 (7), 1289-1294, 2009 | 19 | 2009 |
Identification of dehydroxytrichostatin A as a novel up-regulator of the ATP-binding cassette transporter A1 (ABCA1) Y Xu, Y Xu, Y Bao, B Hong, S Si Molecules 16 (9), 7183-7198, 2011 | 18 | 2011 |
A novel compound 4010B-30 upregulates apolipoprotein AI gene expression through activation of PPARγ in HepG2 cells Y Du, L Wang, S Si, Y Yang, B Hong Atherosclerosis 239 (2), 589-598, 2015 | 12 | 2015 |
Synthesis and structure–activity relationship of N-(2-arylethyl) isoquinoline derivatives as human scavenger receptor CD36 antagonists YX Wang, L Wang, YN Xu, YH Li, JD Jiang, SY Si, YB Li, G Ren, YQ Shan, ... European journal of medicinal chemistry 46 (4), 1066-1073, 2011 | 11 | 2011 |
Low-density lipoprotein upregulate SR-BI through Sp1 Ser702 phosphorylation in hepatic cells F Yang, Y Du, J Zhang, Z Jiang, L Wang, B Hong Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids …, 2016 | 10 | 2016 |
High-density lipoprotein-based drug discovery for treatment of atherosclerosis Y Du, L Wang, B Hong Expert opinion on drug discovery 10 (8), 841-855, 2015 | 10 | 2015 |
Design, synthesis and biological evaluation of hydroxamic acid derivatives as potential high density lipoprotein (HDL) receptor CLA-1 up-regulating agents X Chen, L Wang, Y Du, Y Wu, X Jia, Y Yang, B Hong Molecules 16 (11), 9178-9193, 2011 | 9 | 2011 |
Advances in the role of microRNAs in lipid metabolism-related anti-atherosclerotic drug discovery L Wang, Y Yang, B Hong Expert opinion on drug discovery 8 (8), 977-990, 2013 | 7 | 2013 |
Substituted benzamides containing azaspiro rings as upregulators of apolipoprotein AI transcription Y Du, Y Yang, W Jiang, L Wang, XJ Jia, SY Si, XF Chen, B Hong Molecules 17 (6), 7379-7386, 2012 | 6 | 2012 |
How can high-throughput screening deliver drugs to treat atherosclerosis? Y Yang, L Wang, S Si, B Hong Expert opinion on drug discovery 5 (12), 1175-1188, 2010 | 6 | 2010 |
人高密度脂蛋白受体基因 3'UTR 对其 mRNA 稳定性的影响 王丽, 贾晓健, 姜华军, 杜郁, 杨帆, 司书毅, 洪斌 中国医药生物技术 8 (1), 29-35, 2013 | 2 | 2013 |